Skip to main content

First Choice Healthcare Solutions, Inc.

corporate_fare Company Profile

First Choice Healthcare Solutions, Inc.

FCHS·OTC·Industrial Applications And Services·CIK 0001416876

First Choice Healthcare Solutions, Inc. (FCHS) is transitioning its business strategy from its historical orthopedic services to developing a national chain of medical functional health and wellness clinics. These clinics will focus on providing life improvement services, including anti-aging, weight management, and hormone replacement, along with pharmacy services, in high-growth markets across the U.S. While the company currently offers limited rehabilitative services like physical therapy, it plans to discontinue all remaining legacy orthopedic and physical therapy services to concentrate resources on building and operating the new medical functional health and wellness clinics. FCHS has operated as a Delaware corporation since February 13, 2012. Historically, the company operated through two wholly owned subsidiaries: FCID Medical, Inc., which owns and operates First Choice Medical Group of Brevard, LLC, its original medical services practice, and The Good Clinic Properties, LLC, which leased clinic facilities. For the years ended December 31, 2025 and 2024, the company reported net losses of approximately $7,056,537 and $3,941,488, respectively, with corresponding cash outflows from operations of $549,019 and $1,706,636. As of December 31, 2025 and 2024, the accumulated deficit was $74,743,067 and $67,781,149. The future strategy will utilize a corporate structure with centralized management services under Leading Primary Care, Inc., and three operating subsidiaries: Live Well Medical Group (for national primary care clinic locations), The Good Clinic Properties, Inc. (for leases on physical clinic locations), and Live Well Drugstore, Inc.

First Choice Healthcare Solutions, Inc. (OTC:FCHS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for FCHS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-19, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for FCHS spans 8-K, 10-Q, S-1/A, 10-K.

Recent high-impact activity:

  • First Choice Healthcare Details $21.3M Acquisition of Pointe Medical and Live Well Drugstore
  • First Choice Healthcare Reports $8.4M Loss, Going Concern Doubt, and Details of SPAC Merger
  • First Choice Healthcare Solutions Inks $650M SPAC Deal with Westin Acquisition Corp.
  • First Choice Healthcare Reports Near-Zero Revenue, Critical Cash Levels, and Deepening Losses; Reiterates Going Concern Warning Amidst Heavy Dilutive Debt Reliance
  • First Choice Healthcare Solutions Launches $19M 'All-or-None' Offering at Deep Discount to Fund Strategic Pivot

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$6.96M
Diluted EPS
-$0.21
Op. Cash Flow
-$549.02K
Gross Profit
$7.35K
Operating Income
-$2.67M
Cash & Equivalents
$5.9K
Debt / Equity
0.00×
Shares Outstanding
32.96M sh
Source: 10-K · filed 2026-03-11 · accession 0001493152-26-009679

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 49 shares in FCHS as of the September 15, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On September 29, 2026, 50.0% of FCHS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)49 shares as of September 15, 2026
Change vs prior period 0.0%
Days to cover1.00 at avg daily volume of 19,162
Daily short volume (FINRA facilities)50.0% of 100 shares on September 29, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for FCHS, detected from its recent SEC filings · based on capital-structure filings through 2026-04-14.

1 shelf registration

Launches $19M 'All-or-None' Public Offering · Deep Discount and Extreme Dilution

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with F →
$0.0083 -0.00% today
52-week range · as of 2026-08-19 $0.0015 – $0.51
Market cap
$273.55K
Volume
600 (0.0× avg)
3-mo avg 139.2K
Live data · 2026-10-05 04:24 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed FCHS - Latest Insights

FCHS
Aug 19, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0093
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Aug 13, 2026, 4:54 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0083
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Jul 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.012
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
May 08, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0043
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Apr 14, 2026, 1:41 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Mar 27, 2026, 3:12 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Mar 11, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Feb 02, 2026, 6:17 AM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Jan 30, 2026, 5:30 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0037
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Jan 27, 2026, 6:14 AM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0036
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
FCHS
Jan 16, 2026, 4:26 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.0032
Real-time Price: $0.0083 info
Change: Low Volume info
Market Cap: $273.554K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets